According to a new report, published by KBV research, The Global Medical Biomimetics Market size is expected to reach $57.7 billion by 2029, rising at a market growth of 6.9% CAGR during the forecast period.
The Dental segment is leading the Global Medical Biomimetics Market by Disease Type in 2022 thereby, achieving a market value of $17.1 billion by 2029. This is due to an increase in the use of dental biomimetics goods, the availability of various biomimetics products for dental disorders, and the rise in the prevalence of dental diseases. It fixes weak, broken, and damaged teeth to preserve their strength and protect them from bacteria. Cutting teeth down for crowns and destructive root canal therapy has virtually disappeared in dental offices around the world due to biomimetic dentistry.
The Drug Delivery segment is showcasing a CAGR of 7.7% during (2023 - 2029). The growth is attributed to the movement in patient preferences toward using sophisticated drug administration systems and rising research and development. Albumin-based delivery has been the most effective method for biomimetics therapies, and medicines containing liraglutide, Abraxane, albiglutide are widely available on the market. Another intriguing application of biomimetics in medicine is cell-based biomimetic delivery.
The North America market dominated the Global Medical Biomimetics Market by Region in 2022, and would continue to be a dominant market till 2029; thereby, achieving a market value of $24.3 billion by 2029. The Europe market is exhibiting a CAGR of 6.4% during (2023 - 2029). Additionally, The Asia Pacific market would showcase a CAGR of 7.8% during (2023 - 2029).
Full Report: https://www.kbvresearch.com/medical-biomimetics-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Zimmer Biomet Holdings, Inc., BioHorizons, Inc. (Henry Schein, Inc.), SynTouch Inc., CorNeat Vision Ltd., Osteopore International Pte Ltd, Curasan, Inc., Otsuka Medical Devices Co., Ltd. (Otsuka Holdings Co. Ltd.), Swedish Biomimetics 3000 ApS, Keystone Dental Group and Blatchford Limited.
By Disease Type
By Application
By Geography
Companies Profiled
Unique Offerings 
